Home » FDA Notifies Ash Access of Approved IDE for MethLock
FDA Notifies Ash Access of Approved IDE for MethLock
The FDA has approved a clinical trial for a new and much more effective formulation of MethLock, a catheter lock solution developed by Ash Access Technology, a Lafayette, Ind., company focused on vascular access medical solutions to prevent catheter-related bloodstream infections (CRBSI).
Yahoo News (http://biz.yahoo.com/prnews/050322/detu012_3.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May